Notably, the inflammation-associated NFκB signaling pathway contributes to inflammation-associated eRNA synthesis and positively regulates enhancer transcription to form a multi-cascade regulatory transcription that affects various inflammatory immune diseases, such as gastritis, SLE and inflammatory bowel disease. This evidence concerns the gene NFKB1 and gastritis.